Position in IRD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,910,737
+$1,730,914 QoQ
Shares Held
464,900
+1076.3% QoQ
Ownership
0.559%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 102 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in IRD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. IRD ranks #218 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in IRD
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,910,737 | 464,900 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $179,823 | 39,522 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $57,616 | 28,665 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $47,199 | 28,606 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $26,888 | 28,606 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $28,032 | 28,606 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $34,040 | 28,606 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $73,484 | 56,096 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $85,839 | 56,105 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $112,788 | 56,114 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $168,902 | 56,114 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $98,248 | 29,328 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $133,879 | 30,848 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $107,302 | 28,614 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $116,986 | 33,141 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $65,532 | 32,603 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $66,557 | 34,666 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $75,573 | 23,325 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $79,542 | 21,325 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $98,674 | 19,160 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $72,124 | 13,660 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $35,766 | 6,156 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $4,543 | 700 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||